Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

Overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is critical in combating EGFR-mutant non-small cell lung cancer (NSCLC). We tried to construct a novel therapeutic strategy to conquer the resistance to second-and third-generation EGFR-TKIs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Akiko, Seike, Masahiro, Chiba, Mika, Takahashi, Satoshi, Nakamichi, Shinji, Matsumoto, Masaru, Takeuchi, Susumu, Minegishi, Yuji, Noro, Rintaro, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173712/
https://www.ncbi.nlm.nih.gov/pubmed/30291293
http://dx.doi.org/10.1038/s41598-018-33190-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173712/
https://www.ncbi.nlm.nih.gov/pubmed/30291293
http://dx.doi.org/10.1038/s41598-018-33190-8

Ejemplares similares